Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
Zhaowei Meng(Tianjin Medical University General Hospital), Shunichi Yamashita(Fukushima Medical University)
Cited by 37
Related Papers
Compound Heterozygous Deletion of the<i>PROP</i>-1 Gene in Children with Combined Pituitary Hormone Deficiency
|The Journal of Clinical Endocrinology & Metabolism|1998|127
The Selective Tyrosine Kinase Inhibitor, STI571, Inhibits Growth of Anaplastic Thyroid Cancer Cells
|The Journal of Clinical Endocrinology & Metabolism|2003|82
Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy
|International Journal of Molecular Sciences|2019|23
Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma
|Scientific Reports|2021|20
8th International Workshop on Microbeam Probes of Cellular Radiation Response
|Journal of Radiation Research|2009|2